Joshua K. Ko

Sar, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Isoliquiritigenin from Licorice Attenuates Metastatic Development of Pancreatic Cancer by Regulation of Selective Autophagy-Mediated Ferroptosis and the Tumor Microenvironment.

Isoliquiritigenin from Licorice Attenuates Metastatic Development of Pancreatic Cancer by Regulation of Selective Autophagy-Mediated Ferroptosis and the Tumor Microenvironment.

Journal: The American journal of Chinese medicine

Published: August 29, 2026

Beyond PAD Inhibition: Emerging Avenues and Natural Products for Targeting Citrullination in Immune Diseases.

Beyond PAD Inhibition: Emerging Avenues and Natural Products for Targeting Citrullination in Immune Diseases.

Journal: Biomedicines

Published: February 27, 2026

Advancement in preclinical development of cancer treatment agents through modulation of Rac1: From EHop-016 to natural products.

Advancement in preclinical development of cancer treatment agents through modulation of Rac1: From EHop-016 to natural products.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: September 12, 2025

Vancomycin-sensitive gut microbiota mediate Dendrobii β-1,4-mannan degradation and anti-colitis activity in mice.

Vancomycin-sensitive gut microbiota mediate Dendrobii β-1,4-mannan degradation and anti-colitis activity in mice.

Journal: International journal of biological macromolecules

Published: March 14, 2025

Nanomaterials in the treatment and diagnosis of rheumatoid arthritis: Advanced approaches.

Nanomaterials in the treatment and diagnosis of rheumatoid arthritis: Advanced approaches.

Journal: SLAS technology

Published: October 02, 2023

Therapeutic Intervention in Cancer by Isoliquiritigenin from Licorice: A Natural Antioxidant and Redox Regulator.

Therapeutic Intervention in Cancer by Isoliquiritigenin from Licorice: A Natural Antioxidant and Redox Regulator.

Journal: Antioxidants (Basel, Switzerland)

Published: May 31, 2022

Isoliquiritigenin inhibits pancreatic cancer progression through blockade of p38 MAPK-regulated autophagy.

Isoliquiritigenin inhibits pancreatic cancer progression through blockade of p38 MAPK-regulated autophagy.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: April 08, 2022

The human cathelicidin peptide LL-37 inhibits pancreatic cancer growth by suppressing autophagy and reprogramming of the tumor immune microenvironment.

The human cathelicidin peptide LL-37 inhibits pancreatic cancer growth by suppressing autophagy and reprogramming of the tumor immune microenvironment.

Journal: Frontiers in pharmacology

Published: March 28, 2022

MUC1 is responsible for the pro-metastatic potential of calycosin in pancreatic ductal adenocarcinoma.

MUC1 is responsible for the pro-metastatic potential of calycosin in pancreatic ductal adenocarcinoma.

Journal: American journal of cancer research

Published: February 23, 2022

MUC1: Structure, Function, and Clinic Application in Epithelial Cancers.

MUC1: Structure, Function, and Clinic Application in Epithelial Cancers.

Journal: International journal of molecular sciences

Published: May 07, 2021

Cryptotanshinone-Induced p53-Dependent Sensitization of Colon Cancer Cells to Apoptotic Drive by Regulation of Calpain and Calcium Homeostasis.

Cryptotanshinone-Induced p53-Dependent Sensitization of Colon Cancer Cells to Apoptotic Drive by Regulation of Calpain and Calcium Homeostasis.

Journal: The American journal of Chinese medicine

Published: July 17, 2020

The dual roles of calycosin in growth inhibition and metastatic progression during pancreatic cancer development: A "TGF-β paradox".

The dual roles of calycosin in growth inhibition and metastatic progression during pancreatic cancer development: A "TGF-β paradox".

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: August 26, 2019

Showing 1-12 of 29

Last Updated: 09/26/2026